Main category: HIV / AIDS
Also included in: immune system / vaccines
Article date: 09 Sep 2011-1: 00 am PDT window.fbAsyncInit = function {FB.init ({AppId: 'aa16a4bf93f23f07eb33109d5f1134d3', status:, cookie: true Xfbml: true, ChannelUrl: 'http://www.medicalnewstoday.com/scripts/facebooklike.html'});}; (function() {var s = document.createElement('script'); = true e.async; e.src = document.location.protocol + ' / / 'connect.facebook.net/en_US/all.js; document.getElementById('fb-root').appendChild(e);}}()); e-Mail to a friend printing reviews

The human body can produce powerful antibodies by an array of HIV strains to protect cells in the laboratory from an infection. In people, the recent research however shows that this is not, a broadly neutralizing antibodies effective or timely enough in HIV infected individuals effectively block progression of infection are produced, appear only after a person with HIV for at least a year - has been infected, where the virus is fully established within the body.

They claim in an article of the perspective, the this week in the New England Journal of medicine, scientists at the National Institute of Allergy and infectious diseases (NIAID), part of the national institutes of health that a key to develop HIV vaccines aim to prevent HIV infection, by you inducing effective immune responses than those which occur naturally.

In her article, the authors examine the challenges of the development of HIV vaccines that can effectively raise these broadly neutralizing antibodies. In particular, they describe work on HIV vaccines based on the way to design the structure, as well as neutralize efforts to gain a better understanding of the evolutionary processes that human B cells undergo largely to produce HIV antibodies.

The authors conclude that the availability of new research, together tools with increased understanding of the human immune response against HIV, they make optimistic that an HIV vaccine, which provides significant protection against acquisition of HIV can be achieved.

Articles from medical news today adapted from original press release.

Visit our HIV / aids section for the latest news on this topic.

MI Johnston and as Fauci. HIV-vaccine development - natural immunity to improve. New England Journal of medicine DOI: 10.1056/NEJMp1107621 (2011).
NIAID Director Anthony S. Fauci, m.d., is a co-author of the paper.
NIH/National Institute of Allergy and infectious diseases, please use one of the following formats, to quote this article in your essay, paper, or report:

APA
NIH/National Institute of Allergy and infectious D (2011, September 9). New progress largely protective HIV vaccines provide reason for optimism in development. Medical news today. Retrieved 9 September 2011 by http://www.medicalnewstoday.com/releases/234090.php MLA
NIH-National Institute for "Provide allergy and infectious D. new advances cause for optimism in the development of vaccines and large protective HIV". Medical news today, September 9 2011. Web. 9 Sep, 2011.

Please note: If no information about the author is specified, the source is quoted instead.

Please note that we publish your name, but we publish your e-Mail address. It is used only so that you know when your message is published. We use it for any other purpose. See our privacy policy for more information.

If you write about certain drugs or operations, No please health care professionals name by name.

All submissions are moderated before, is included (in order to stop spam)

Contact our news editor

Please use our feedback form for corrections of factual information, or to the editor.

Please send medical news or health press press releases to:

Note: all medical information on this website is published not a substitute for well-founded advice and you should take any action before consulting with a health care professional. For more information, please read our terms and conditions.

View the original article here

Peliculas Online